Key terms
About PSTV
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PSTV news
Mar 25
8:14am ET
Plus Therapeutics announces validation, implementation of CSF-01 diagnostic
Mar 22
12:45pm ET
Buy Rating Affirmed for Plus Therapeutics Amidst Clinical Advancements and Industry Tailwinds
Mar 22
12:40pm ET
Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV) and Milestone Pharmaceuticals (MIST)
Mar 13
8:12am ET
Plus Therapeutics CEO’s Insightful Presentation Now Available
Mar 11
7:28am ET
Plus Therapeutics completes dosing in Cohort 5 of ReSPECT-LM Phase 1 trial
Mar 07
10:35am ET
Buy Rating Affirmed for Plus Therapeutics Amid Strong Financials and Promising Clinical Trials
Mar 07
1:01am ET
Plus Therapeutics Is Worried About This – Should You Be Worried Too?
Mar 05
4:16pm ET
Plus Therapeutics reports FY23 EPS ($4.24) vs ($11.58) last year
No recent press releases are available for PSTV
PSTV Financials
Key terms
Ad Feedback
PSTV Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PSTV Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
